MR-guided percutaneous sclerotherapy of low-flow vascular malformations: Clinical experience using a 1.5 tesla MR

Daniel M O'Mara1, Paul A DiCamillo2, Wesley D Gilson3

  • 1Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Abstract

Insights

Image-guided sclerotherapy using 1.5T MR is a safe and effective treatment for low-flow vascular malformations. This technique significantly reduces procedure times and improves patient symptoms with a low complication rate.

Area of Science:

  • Medical Imaging
  • Interventional Radiology
  • Vascular Surgery

Background:

  • Low-flow vascular malformations present diagnostic and therapeutic challenges.
  • Image guidance is crucial for precise intervention in vascular lesions.

Purpose of the Study:

  • To assess the feasibility, safety, and effectiveness of 1.5 Tesla (T) MR-guided sclerotherapy for low-flow vascular malformations.
  • To evaluate the impact of real-time MR guidance on procedure efficiency and patient outcomes.

Main Methods:

  • Thirty-three sclerotherapy procedures were performed on 22 patients using real-time 1.5T MR guidance and in-suite fluoroscopy.
  • Quantitative analysis of planning, targeting, intervention, and total procedure times.
  • Qualitative assessment of therapeutic success and complication rates.

Main Results:

  • Technical success was achieved in 29 of 33 procedures (88%).
  • Significant reductions were observed in targeting time (P=0.043), intervention time (P=0.022), and total procedure time (P=0.046) with experience.
  • 82% of patients experienced improvement in predominant symptoms, with a significant decrease in pain (P<0.001).
  • A minor complication rate of 3% was recorded, with no major complications.

Conclusions:

  • MR-guided percutaneous sclerotherapy is a safe and effective modality for treating low-flow vascular malformations.
  • The technique demonstrates versatility across various anatomical locations.
  • Real-time MR guidance enhances procedural efficiency and patient symptom management.